Prices of cancer, cardiac drugs may be slashed

This is a departure from the existing mechanism in which all essential
medicines automatically go under price control. The Standing National
Committee will decide which medicines should be available in adequate
numbers and assured quality.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/prices-of-cancer-cardiac-drugs-may-be-slashed/articleshow/71798680.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment